{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T16:15:52Z","timestamp":1760890552314,"version":"3.32.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-024-04724-7","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T05:31:12Z","timestamp":1735018272000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of transcutaneous electrical acupoint stimulation for immunological non-responder in HIV\/AIDS combined with amphetamine abuse: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Tao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuoliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoujun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"issue":"1","key":"4724_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/imr.12823","volume":"292","author":"C Fenwick","year":"2019","unstructured":"Fenwick C, et al. T-cell exhaustion in HIV infection. Immunol Rev. 2019;292(1):149\u201363.","journal-title":"Immunol Rev"},{"issue":"42","key":"4724_CR2","doi-asserted-by":"publisher","first-page":"943","DOI":"10.46234\/ccdcw2023.177","volume":"5","author":"Z Dou","year":"2023","unstructured":"Dou Z, et al. Trends in Mortality and Prevalence of Reported HIV\/AIDS Cases - China, 2002\u20132021. China CDC Wkly. 2023;5(42):943\u20137.","journal-title":"China CDC Wkly"},{"issue":"Suppl 1","key":"4724_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/add.12783","volume":"110","author":"W Luo","year":"2015","unstructured":"Luo W, et al. Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in China. Addiction. 2015;110(Suppl 1):61\u20137.","journal-title":"Addiction"},{"issue":"9739","key":"4724_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S0140-6736(10)60753-2","volume":"376","author":"G Colfax","year":"2010","unstructured":"Colfax G, et al. Amphetamine-group substances and HIV. Lancet. 2010;376(9739):458\u201374.","journal-title":"Lancet"},{"key":"4724_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1196\/annals.1316.055","volume":"1025","author":"K Kulsudjarit","year":"2004","unstructured":"Kulsudjarit K. Drug problem in southeast and southwest Asia. Ann N Y Acad Sci. 2004;1025:446\u201357.","journal-title":"Ann N Y Acad Sci"},{"key":"4724_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2458-11-20","volume":"11","author":"BD Marshall","year":"2011","unstructured":"Marshall BD, et al. Pathways to HIV risk and vulnerability among lesbian, gay, bisexual, and transgendered methamphetamine users: a multi-cohort gender-based analysis. BMC Public Health. 2011;11:20.","journal-title":"BMC Public Health"},{"issue":"9","key":"4724_CR7","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1007\/s10461-018-2147-9","volume":"22","author":"EV Pitpitan","year":"2018","unstructured":"Pitpitan EV, et al. Mood, Meth, Condom Use, and Gender: Latent Growth Curve Modeling Results from a Randomized Trial. AIDS Behav. 2018;22(9):2815\u201329.","journal-title":"AIDS Behav"},{"issue":"01","key":"4724_CR8","first-page":"54","volume":"27","author":"CCFD Prevention","year":"2021","unstructured":"Prevention CCFD. Core information on HIV prevention in 2020. Health Guide. 2021;27(01):54.","journal-title":"Health Guide"},{"issue":"4","key":"4724_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11904-005-0016-4","volume":"2","author":"G Colfax","year":"2005","unstructured":"Colfax G, Shoptaw S. The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV\/AIDS Rep. 2005;2(4):194\u20139.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1\u20133","key":"4724_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.drugalcdep.2009.02.002","volume":"102","author":"A Ober","year":"2009","unstructured":"Ober A, et al. Factors associated with event-level stimulant use during sex in a sample of older, low-income men who have sex with men in Los Angeles. Drug Alcohol Depend. 2009;102(1\u20133):123\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"1\u20132","key":"4724_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3109\/10826080902869620","volume":"45","author":"WS Cheng","year":"2010","unstructured":"Cheng WS, et al. Binge use and sex and drug use behaviors among HIV(-), heterosexual methamphetamine users in San Diego. Subst Use Misuse. 2010;45(1\u20132):116\u201333.","journal-title":"Subst Use Misuse"},{"issue":"2","key":"4724_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/jama.2016.5148","volume":"316","author":"AJ Rodger","year":"2016","unstructured":"Rodger AJ, et al. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. JAMA. 2016;316(2):171\u201381.","journal-title":"JAMA"},{"issue":"8","key":"4724_CR13","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nm.4108","volume":"22","author":"SG Deeks","year":"2016","unstructured":"Deeks SG, et al. International AIDS Society global scientific strategy: towards an HIV cure 2016. Nat Med. 2016;22(8):839\u201350.","journal-title":"Nat Med"},{"issue":"3","key":"4724_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/QAI.0b013e3181ca3f7c","volume":"53","author":"C Erikstrup","year":"2010","unstructured":"Erikstrup C, et al. T-cell dysfunction in HIV-1-infected patients with impaired recovery of CD4 cells despite suppression of viral replication. J Acquir Immune Defic Syndr. 2010;53(3):303\u201310.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"4724_CR15","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1097\/QAD.0b013e32833adbcf","volume":"24","author":"JJ Lok","year":"2010","unstructured":"Lok JJ, et al. Long-term increase in CD4\u2009+\u2009T-cell counts during combination antiretroviral therapy for HIV-1 infection. AIDS. 2010;24(12):1867\u201376.","journal-title":"AIDS"},{"issue":"4","key":"4724_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/JLB.4MR1019-189R","volume":"107","author":"X Yang","year":"2020","unstructured":"Yang X, et al. Incomplete immune reconstitution in HIV\/AIDS patients on antiretroviral therapy: Challenges of immunological non-responders. J Leukoc Biol. 2020;107(4):597\u2013612.","journal-title":"J Leukoc Biol"},{"issue":"6","key":"4724_CR17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1086\/597093","volume":"48","author":"CF Kelley","year":"2009","unstructured":"Kelley CF, et al. Incomplete peripheral CD4\u2009+\u2009cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis. 2009;48(6):787\u201394.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"4724_CR18","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1086\/379894","volume":"188","author":"RJ Ellis","year":"2003","unstructured":"Ellis RJ, et al. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis. 2003;188(12):1820\u20136.","journal-title":"J Infect Dis"},{"issue":"3","key":"4724_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11481-015-9604-2","volume":"10","author":"RC Passaro","year":"2015","unstructured":"Passaro RC, et al. The Complex Interaction Between Methamphetamine Abuse and HIV-1 Pathogenesis. J Neuroimmune Pharmacol. 2015;10(3):477\u201386.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"9","key":"4724_CR20","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/cid\/cir552","volume":"53","author":"T Li","year":"2011","unstructured":"Li T, et al. Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy. Clin Infect Dis. 2011;53(9):944\u201351.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"4724_CR21","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1182\/blood-2011-01-329060","volume":"118","author":"S Piconi","year":"2011","unstructured":"Piconi S, et al. Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders. Blood. 2011;118(12):3263\u201372.","journal-title":"Blood"},{"key":"4724_CR22","doi-asserted-by":"crossref","unstructured":"Mokgalaboni K et al. A Systematic Review and Meta-Analysis on the Impact of Statin Treatment in HIV Patients on Antiretroviral Therapy. Int J Environ Res Public Health, 2023. 20(9).","DOI":"10.3390\/ijerph20095668"},{"issue":"12","key":"4724_CR23","doi-asserted-by":"publisher","first-page":"e116306","DOI":"10.1371\/journal.pone.0116306","volume":"9","author":"M Somsouk","year":"2014","unstructured":"Somsouk M, et al. The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD4\u2009+\u2009T cell recovery: a randomized crossover trial. PLoS ONE. 2014;9(12):e116306.","journal-title":"PLoS ONE"},{"issue":"5","key":"4724_CR24","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/infdis\/jiu515","volume":"211","author":"AR Tenorio","year":"2015","unstructured":"Tenorio AR, et al. Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286. J Infect Dis. 2015;211(5):780\u201390.","journal-title":"J Infect Dis"},{"issue":"51","key":"4724_CR25","doi-asserted-by":"publisher","first-page":"20476","DOI":"10.1073\/pnas.0810843106","volume":"105","author":"A Heredia","year":"2008","unstructured":"Heredia A, et al. Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1. Proc Natl Acad Sci U S A. 2008;105(51):20476\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4724_CR26","doi-asserted-by":"crossref","unstructured":"Liu F et al. Acupuncture & its ability to restore and maintain immune homeostasis. QJM, 2023.","DOI":"10.1093\/qjmed\/hcad134"},{"key":"4724_CR27","doi-asserted-by":"publisher","first-page":"1147718","DOI":"10.3389\/fimmu.2023.1147718","volume":"14","author":"M Wang","year":"2023","unstructured":"Wang M, et al. The immunomodulatory mechanisms for acupuncture practice. Front Immunol. 2023;14:1147718.","journal-title":"Front Immunol"},{"issue":"7","key":"4724_CR28","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1142\/S0192415X19500745","volume":"47","author":"YL Chi","year":"2019","unstructured":"Chi YL, et al. Transcutaneous Electrical Acupoint Stimulation for Improving Postoperative Recovery, Reducing Stress and Inflammatory Responses in Elderly Patient Undergoing Knee Surgery. Am J Chin Med. 2019;47(7):1445\u201358.","journal-title":"Am J Chin Med"},{"key":"4724_CR29","unstructured":"J, C. and C. W, Mechanisms of acupuncture in regulating immune function. Liaoning J Traditional Chin Med, 2006(02): pp. 210\u20131."},{"issue":"06","key":"4724_CR30","first-page":"110","volume":"36","author":"S X","year":"2016","unstructured":"X. S, et al. Effects of transcutaneous acupoint electrical stimulation on immune function in traumatized rats. Mod Traditional Chin Med. 2016;36(06):110\u20132.","journal-title":"Mod Traditional Chin Med"},{"key":"4724_CR31","doi-asserted-by":"crossref","unstructured":"Ao L, et al. Effects of transcutaneous electrical acupoint stimulation on perioperative immune function and postoperative analgesia in patients undergoing radical mastectomy: A randomized controlled trial. Experimental And Therapeutic Medicine; 2021;21:3.","DOI":"10.3892\/etm.2021.9615"},{"issue":"4","key":"4724_CR32","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/S1556-0864(16)30167-8","volume":"11","author":"LL Hou","year":"2016","unstructured":"Hou LL, Gu F, Zhou C. Transcutaneous electrical acupoint stimulation ameliorates chemotherapy-induced bone marrow suppression in lung cancer patients. J Thorac Oncol. 2016;11(4):S77\u201377.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"4724_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3892\/etm.2015.2913","volume":"11","author":"HX Wu","year":"2016","unstructured":"Wu HX, et al. Effects of transcutaneous acupoint electrical stimulation on the imbalance of Th1, Th2, Th17 and Treg cells following thoracotomy of patients with lung cancer. Experimental Therapeutic Med. 2016;11(2):495\u2013502.","journal-title":"EXPERIMENTAL THERAPEUTIC Med"},{"key":"4724_CR34","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ"},{"issue":"2","key":"4724_CR35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1590\/S2317-17822013000200017","volume":"25","author":"DE Battle","year":"2013","unstructured":"Battle DE. Diagnostic and Statistical Manual of Mental Disorders (DSM). Codas. 2013;25(2):191\u20132.","journal-title":"Codas"},{"issue":"02","key":"4724_CR36","first-page":"281","volume":"35","author":"BOCA Anti-AIDS","year":"2020","unstructured":"Anti-AIDS BOCA. Expert Consensus on the Integrated Traditional Chinese and Western Medicine Treatment for Immunological Dysfunction in HIV\/AIDS. Chin J Traditional Chin Med. 2020;35(02):281\u20134.","journal-title":"Chin J Traditional Chin Med"},{"issue":"2","key":"4724_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1179\/1528433614Z.0000000005","volume":"16","author":"T Li","year":"2015","unstructured":"Li T, et al. Tripterygium wilfordii Hook F extract in cART-treated HIV patients with poor immune response: a pilot study to assess its immunomodulatory effects and safety. HIV Clin Trials. 2015;16(2):49\u201356.","journal-title":"HIV Clin Trials"},{"issue":"5","key":"4724_CR38","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.jhep.2007.02.015","volume":"46","author":"E Christensen","year":"2007","unstructured":"Christensen E. Methodology of superiority vs. equivalence trials and non-inferiority trials. J Hepatol. 2007;46(5):947\u201354.","journal-title":"J Hepatol"},{"key":"4724_CR39","doi-asserted-by":"publisher","first-page":"1236460","DOI":"10.3389\/fmicb.2023.1236460","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang W, Ruan L. Recent advances in poor HIV immune reconstitution: what will the future look like? Front Microbiol. 2023;14:1236460.","journal-title":"Front Microbiol"},{"key":"4724_CR40","unstructured":"Diseases CSOI, Prevention CCFD. Chinese Guideline for the Diagnosis and Treatment of HIV\/AIDS (2021 edition). Journal of Peking University Medicine, 2022;13(02):203\u2013226."},{"key":"4724_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1745-6215-10-75","volume":"10","author":"H Zheng","year":"2009","unstructured":"Zheng H, et al. Acupuncture as a treatment for functional dyspepsia: design and methods of a randomized controlled trial. Trials. 2009;10:75.","journal-title":"Trials"},{"issue":"08","key":"4724_CR42","first-page":"748","volume":"50","author":"Y X","year":"2009","unstructured":"X Y, et al. A review of non-traditional acupoint selection methods in acupuncture research at home and abroad. Chin J Traditional Chin Med. 2009;50(08):748\u201350.","journal-title":"Chin J Traditional Chin Med"},{"key":"4724_CR43","unstructured":"Gao J. Effects of moxibustion on immune function and gut microbiota diversity in 200 patients with immunological dysfunction in HIV\/AIDS. 2022.China Academy of Chinese Medical Sciences. p. 115."},{"issue":"1","key":"4724_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12865-019-0311-2","volume":"20","author":"CX Li","year":"2019","unstructured":"Li CX, et al. The predictive role of CD4(+) cell count and CD4\/CD8 ratio in immune reconstitution outcome among HIV\/AIDS patients receiving antiretroviral therapy: an eight-year observation in China. BMC Immunol. 2019;20(1):31.","journal-title":"BMC Immunol"},{"issue":"3","key":"4724_CR45","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1016\/S2352-3018(15)00018-1","volume":"2","author":"S Serrano-Villar","year":"2015","unstructured":"Serrano-Villar S, Deeks SG. CD4\/CD8 ratio: an emerging biomarker for HIV. Lancet HIV. 2015;2(3):e76\u20137.","journal-title":"Lancet HIV"},{"issue":"6","key":"4724_CR46","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1172\/JCI200317533","volume":"112","author":"MK Hellerstein","year":"2003","unstructured":"Hellerstein MK, et al. Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. J Clin Invest. 2003;112(6):956\u201366.","journal-title":"J Clin Invest"},{"issue":"11","key":"4724_CR47","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1086\/375239","volume":"187","author":"SR Ostrowski","year":"2003","unstructured":"Ostrowski SR, et al. A low level of CD4\u2009+\u2009CD28\u2009+\u2009T cells is an independent predictor of high mortality in human immunodeficiency virus type 1-infected patients. J Infect Dis. 2003;187(11):1726\u201334.","journal-title":"J Infect Dis"},{"issue":"1","key":"4724_CR48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12967-020-02245-8","volume":"18","author":"CB Song","year":"2020","unstructured":"Song CB, et al. CD4(+)CD38(+) central memory T cells contribute to HIV persistence in HIV-infected individuals on long-term ART. J Transl Med. 2020;18(1):95.","journal-title":"J Transl Med"},{"issue":"4","key":"4724_CR49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/cyto.b.20467","volume":"76","author":"E Tuaillon","year":"2009","unstructured":"Tuaillon E, et al. Close association of CD8+\/CD38 bright with HIV-1 replication and complex relationship with CD4\u2009+\u2009T-cell count. Cytometry B Clin Cytom. 2009;76(4):249\u201360.","journal-title":"Cytometry B Clin Cytom"},{"issue":"2","key":"4724_CR50","doi-asserted-by":"publisher","first-page":"e1007619","DOI":"10.1371\/journal.ppat.1007619","volume":"15","author":"M Pardons","year":"2019","unstructured":"Pardons M, et al. Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection. PLoS Pathog. 2019;15(2):e1007619.","journal-title":"PLoS Pathog"},{"key":"4724_CR51","doi-asserted-by":"publisher","first-page":"c869","DOI":"10.1136\/bmj.c869","volume":"340","author":"D Moher","year":"2010","unstructured":"Moher D, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.","journal-title":"BMJ"},{"issue":"2","key":"4724_CR52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/aim.2009.001370","volume":"28","author":"H MacPherson","year":"2010","unstructured":"MacPherson H, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. Acupunct Med. 2010;28(2):83\u201393.","journal-title":"Acupunct Med"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-024-04724-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-024-04724-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-024-04724-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T18:02:34Z","timestamp":1735063354000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-024-04724-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4724"],"URL":"https:\/\/doi.org\/10.1186\/s12906-024-04724-7","relation":{},"ISSN":["2662-7671"],"issn-type":[{"type":"electronic","value":"2662-7671"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol was approved by the Medical Ethics Committee of Chengdu University of Traditional Chinese Medicine Affiliated Hospital on August 30, 2023, with approval number 2023 kl-124-1. Participants provide written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"20230818, v4.0.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Protocol version"}}],"article-number":"424"}}